{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-005467","form_type":"8-K","ticker":"ACHC","cik":"0001520697","company_name":"Acadia Healthcare Company, Inc.","filed_at":"2025-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.873569+00:00","generated_at":"2026-05-26T01:38:07.881727+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"medium","headline":"Acadia Healthcare Q4 2024 revenue $774.2M (+4.2%); adj. EPS $0.64; announces $300M buyback","bullets":["Q4 net income $32.6M ($0.35 diluted EPS); adjusted income $59.2M ($0.64 diluted EPS).","Same-facility revenue +4.7% YoY on patient days +3.2% and revenue per patient day +1.4%.","Adjusted EBITDA $153.1M, including $14.3M professional liability reserve adjustment and $5.0M facility closure impact.","Added 577 newly licensed beds in Q4; completed ~1,300 newly constructed beds in FY2024.","Board authorized new $300M share repurchase program; FY2025 and Q1 2025 guidance provided."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-005467","json":"https://secwatch.observer/filing/0001437749-25-005467.json","markdown":"https://secwatch.observer/filing/0001437749-25-005467.md","text":"https://secwatch.observer/filing/0001437749-25-005467.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1520697/000143774925005467/0001437749-25-005467-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1520697/000143774925005467/achc20250227_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T01:38:07.881727+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}